2004

SPIRIT FIRST 30-Day and FUTURE II One-Year Results Continue to Support Benefit of Everolimus Eluting Coronary Stents Indianapolis, Ind., and Paris - Guidant Corporation (NYSE: GDT) today announced...

Evalve, Inc.''s Innovative Technology Designed to Offer New Treatment Option for Debilitating Condition Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...

Trial Results Support Therapy for Extending and Improving the Lives of People with Advanced Heart Failure Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...

Dollens will Remain President and CEO Until His Retirement; Guido J. Neels Elevated to Chief Operating Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will announce today at its...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a second quarter dividend of $0.10 per share on outstanding common stock. This...

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host a mid-quarter conference call to provide an update on the company''s business. The...

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), today announced that it will participate in the Deutsche Bank Securities 29th Annual Healthcare Conference on...

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), today announced that it will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May...

Worldwide implantable defibrillator revenue of $405 million, up 22 percent. Worldwide stent revenue of $171 million, down 22 percent. Progress on drug-eluting stent programs through achievement of...

Stent Successfully Treats Patients with Difficult Coronary Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced Conformité Européenne (CE) Mark...